HB 2100·KS·house
Establishing statewide standards governing the use of HIV post-exposure prophylaxis, permitting a pharmacist to initiate such medication to certain patients, providing civil liability protections to pharmacists who initiate prophylactic therapy to patients for post-exposure to human immunodeficiency virus.
FailedFiled Jan 27, 2025
Sponsor: Brandon Woodard (D)
Latest Action
Died in Committee
Apr 10, 2026
Topics
Track this bill
Get real-time alerts when HB 2100 changes status, plus AI-powered summaries and stage predictions.
Sign up free